Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract.
The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics. Older population has higher risk of developing glaucoma although other age groups may be affected. Other high risk groups include diabetics and those with a family history of glaucoma. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Glaucoma Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Glaucoma Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Glaucoma Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Icon Bioscience
Pfizer
Ocular Therapeutix
Lightmed
Allergan
Quantel
Novartis
Amorphex Therapeutics
Lumenis
Merck
Ellex
By Type:
Prostaglandin Analogs (PGAs),
Alpha Agonist
Beta Blockers
Cholinergic Drugs
Carbonic Anhydrase Inhibitors
Others
By End-User:
Hospitals
Home Users
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Glaucoma Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 China Glaucoma Treatment Market Size and Growth Rate of Prostaglandin Analogs (PGAs), from 2016 to 2027
-
1.3.2 China Glaucoma Treatment Market Size and Growth Rate of Alpha Agonist from 2016 to 2027
-
1.3.3 China Glaucoma Treatment Market Size and Growth Rate of Beta Blockers from 2016 to 2027
-
1.3.4 China Glaucoma Treatment Market Size and Growth Rate of Cholinergic Drugs from 2016 to 2027
-
1.3.5 China Glaucoma Treatment Market Size and Growth Rate of Carbonic Anhydrase Inhibitors from 2016 to 2027
-
1.3.6 China Glaucoma Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Glaucoma Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Glaucoma Treatment Market Size and Growth Rate of Home Users from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Glaucoma Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Glaucoma Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Prostaglandin Analogs (PGAs),
-
3.4.2 Market Size and Growth Rate of Alpha Agonist
-
3.4.3 Market Size and Growth Rate of Beta Blockers
-
3.4.4 Market Size and Growth Rate of Cholinergic Drugs
-
3.4.5 Market Size and Growth Rate of Carbonic Anhydrase Inhibitors
-
3.4.6 Market Size and Growth Rate of Others
4 Segmentation of Glaucoma Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Glaucoma Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Glaucoma Treatment in Hospitals
-
4.4.2 Market Size and Growth Rate of Glaucoma Treatment in Home Users
5 Market Analysis by Regions
-
5.1 China Glaucoma Treatment Production Analysis by Regions
-
5.2 China Glaucoma Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Glaucoma Treatment Landscape Analysis
-
6.1 North China Glaucoma Treatment Landscape Analysis by Major Types
-
6.2 North China Glaucoma Treatment Landscape Analysis by Major End-Users
7 Central China Glaucoma Treatment Landscape Analysis
-
7.1 Central China Glaucoma Treatment Landscape Analysis by Major Types
-
7.2 Central China Glaucoma Treatment Landscape Analysis by Major End-Users
8 South China Glaucoma Treatment Landscape Analysis
-
8.1 South China Glaucoma Treatment Landscape Analysis by Major Types
-
8.2 South China Glaucoma Treatment Landscape Analysis by Major End-Users
9 East China Glaucoma Treatment Landscape Analysis
-
9.1 East China Glaucoma Treatment Landscape Analysis by Major Types
-
9.2 East China Glaucoma Treatment Landscape Analysis by Major End-Users
10 Northeast China Glaucoma Treatment Landscape Analysis
-
10.1 Northeast China Glaucoma Treatment Landscape Analysis by Major Types
-
10.2 Northeast China Glaucoma Treatment Landscape Analysis by Major End-Users
11 Southwest China Glaucoma Treatment Landscape Analysis
-
11.1 Southwest China Glaucoma Treatment Landscape Analysis by Major Types
-
11.2 Southwest China Glaucoma Treatment Landscape Analysis by Major End-Users
12 Northwest China Glaucoma Treatment Landscape Analysis
-
12.1 Northwest China Glaucoma Treatment Landscape Analysis by Major Types
-
12.2 Northwest China Glaucoma Treatment Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Icon Bioscience
-
13.1.1 Icon Bioscience Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Ocular Therapeutix
-
13.3.1 Ocular Therapeutix Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Lightmed
-
13.4.1 Lightmed Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Allergan
-
13.5.1 Allergan Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Quantel
-
13.6.1 Quantel Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Novartis
-
13.7.1 Novartis Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Amorphex Therapeutics
-
13.8.1 Amorphex Therapeutics Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Lumenis
-
13.9.1 Lumenis Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Merck
-
13.10.1 Merck Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Ellex
-
13.11.1 Ellex Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Prostaglandin Analogs (PGAs), from 2016 to 2027
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Alpha Agonist from 2016 to 2027
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Beta Blockers from 2016 to 2027
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Cholinergic Drugs from 2016 to 2027
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Carbonic Anhydrase Inhibitors from 2016 to 2027
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Glaucoma Treatment Market Size and Growth Rate of Home Users from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Glaucoma Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Glaucoma Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Glaucoma Treatment
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Glaucoma Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Glaucoma Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Prostaglandin Analogs (PGAs),
-
Figure Market Size and Growth Rate of Alpha Agonist
-
Figure Market Size and Growth Rate of Beta Blockers
-
Figure Market Size and Growth Rate of Cholinergic Drugs
-
Figure Market Size and Growth Rate of Carbonic Anhydrase Inhibitors
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Glaucoma Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Glaucoma Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Home Users
-
Table China Glaucoma Treatment Production by Regions
-
Table China Glaucoma Treatment Production Share by Regions
-
Figure China Glaucoma Treatment Production Share by Regions in 2016
-
Figure China Glaucoma Treatment Production Share by Regions in 2021
-
Figure China Glaucoma Treatment Production Share by Regions in 2027
-
Table China Glaucoma Treatment Consumption by Regions
-
Table China Glaucoma Treatment Consumption Share by Regions
-
Figure China Glaucoma Treatment Consumption Share by Regions in 2016
-
Figure China Glaucoma Treatment Consumption Share by Regions in 2021
-
Figure China Glaucoma Treatment Consumption Share by Regions in 2027
-
Table North China Glaucoma Treatment Consumption by Types from 2016 to 2027
-
Table North China Glaucoma Treatment Consumption Share by Types from 2016 to 2027
-
Figure North China Glaucoma Treatment Consumption Share by Types in 2016
-
Figure North China Glaucoma Treatment Consumption Share by Types in 2021
-
Figure North China Glaucoma Treatment Consumption Share by Types in 2027
-
Table North China Glaucoma Treatment Consumption by End-Users from 2016 to 2027
-
Table North China Glaucoma Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure North China Glaucoma Treatment Consumption Share by End-Users in 2016
-
Figure North China Glaucoma Treatment Consumption Share by End-Users in 2021
-
Figure North China Glaucoma Treatment Consumption Share by End-Users in 2027
-
Table Central China Glaucoma Treatment Consumption by Types from 2016 to 2027
-
Table Central China Glaucoma Treatment Consumption Share by Types from 2016 to 2027
-
Figure Central China Glaucoma Treatment Consumption Share by Types in 2016
-
Figure Central China Glaucoma Treatment Consumption Share by Types in 2021
-
Figure Central China Glaucoma Treatment Consumption Share by Types in 2027
-
Table Central China Glaucoma Treatment Consumption by End-Users from 2016 to 2027
-
Table Central China Glaucoma Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Glaucoma Treatment Consumption Share by End-Users in 2016
-
Figure Central China Glaucoma Treatment Consumption Share by End-Users in 2021
-
Figure Central China Glaucoma Treatment Consumption Share by End-Users in 2027
-
Table South China Glaucoma Treatment Consumption by Types from 2016 to 2027
-
Table South China Glaucoma Treatment Consumption Share by Types from 2016 to 2027
-
Figure South China Glaucoma Treatment Consumption Share by Types in 2016
-
Figure South China Glaucoma Treatment Consumption Share by Types in 2021
-
Figure South China Glaucoma Treatment Consumption Share by Types in 2027
-
Table South China Glaucoma Treatment Consumption by End-Users from 2016 to 2027
-
Table South China Glaucoma Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South China Glaucoma Treatment Consumption Share by End-Users in 2016
-
Figure South China Glaucoma Treatment Consumption Share by End-Users in 2021
-
Figure South China Glaucoma Treatment Consumption Share by End-Users in 2027
-
Table East China Glaucoma Treatment Consumption by Types from 2016 to 2027
-
Table East China Glaucoma Treatment Consumption Share by Types from 2016 to 2027
-
Figure East China Glaucoma Treatment Consumption Share by Types in 2016
-
Figure East China Glaucoma Treatment Consumption Share by Types in 2021
-
Figure East China Glaucoma Treatment Consumption Share by Types in 2027
-
Table East China Glaucoma Treatment Consumption by End-Users from 2016 to 2027
-
Table East China Glaucoma Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure East China Glaucoma Treatment Consumption Share by End-Users in 2016
-
Figure East China Glaucoma Treatment Consumption Share by End-Users in 2021
-
Figure East China Glaucoma Treatment Consumption Share by End-Users in 2027
-
Table Northeast China Glaucoma Treatment Consumption by Types from 2016 to 2027
-
Table Northeast China Glaucoma Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Glaucoma Treatment Consumption Share by Types in 2016
-
Figure Northeast China Glaucoma Treatment Consumption Share by Types in 2021
-
Figure Northeast China Glaucoma Treatment Consumption Share by Types in 2027
-
Table Northeast China Glaucoma Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast China Glaucoma Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Glaucoma Treatment Consumption Share by End-Users in 2016
-
Figure Northeast China Glaucoma Treatment Consumption Share by End-Users in 2021
-
Figure Northeast China Glaucoma Treatment Consumption Share by End-Users in 2027
-
Table Southwest China Glaucoma Treatment Consumption by Types from 2016 to 2027
-
Table Southwest China Glaucoma Treatment Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Glaucoma Treatment Consumption Share by Types in 2016
-
Figure Southwest China Glaucoma Treatment Consumption Share by Types in 2021
-
Figure Southwest China Glaucoma Treatment Consumption Share by Types in 2027
-
Table Southwest China Glaucoma Treatment Consumption by End-Users from 2016 to 2027
-
Table Southwest China Glaucoma Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Glaucoma Treatment Consumption Share by End-Users in 2016
-
Figure Southwest China Glaucoma Treatment Consumption Share by End-Users in 2021
-
Figure Southwest China Glaucoma Treatment Consumption Share by End-Users in 2027
-
Table Northwest China Glaucoma Treatment Consumption by Types from 2016 to 2027
-
Table Northwest China Glaucoma Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Glaucoma Treatment Consumption Share by Types in 2016
-
Figure Northwest China Glaucoma Treatment Consumption Share by Types in 2021
-
Figure Northwest China Glaucoma Treatment Consumption Share by Types in 2027
-
Table Northwest China Glaucoma Treatment Consumption by End-Users from 2016 to 2027
-
Table Northwest China Glaucoma Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Glaucoma Treatment Consumption Share by End-Users in 2016
-
Figure Northwest China Glaucoma Treatment Consumption Share by End-Users in 2021
-
Figure Northwest China Glaucoma Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Icon Bioscience
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Icon Bioscience
-
Figure Sales and Growth Rate Analysis of Icon Bioscience
-
Figure Revenue and Market Share Analysis of Icon Bioscience
-
Table Product and Service Introduction of Icon Bioscience
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Ocular Therapeutix
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ocular Therapeutix
-
Figure Sales and Growth Rate Analysis of Ocular Therapeutix
-
Figure Revenue and Market Share Analysis of Ocular Therapeutix
-
Table Product and Service Introduction of Ocular Therapeutix
-
Table Company Profile and Development Status of Lightmed
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lightmed
-
Figure Sales and Growth Rate Analysis of Lightmed
-
Figure Revenue and Market Share Analysis of Lightmed
-
Table Product and Service Introduction of Lightmed
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Quantel
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quantel
-
Figure Sales and Growth Rate Analysis of Quantel
-
Figure Revenue and Market Share Analysis of Quantel
-
Table Product and Service Introduction of Quantel
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Amorphex Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amorphex Therapeutics
-
Figure Sales and Growth Rate Analysis of Amorphex Therapeutics
-
Figure Revenue and Market Share Analysis of Amorphex Therapeutics
-
Table Product and Service Introduction of Amorphex Therapeutics
-
Table Company Profile and Development Status of Lumenis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lumenis
-
Figure Sales and Growth Rate Analysis of Lumenis
-
Figure Revenue and Market Share Analysis of Lumenis
-
Table Product and Service Introduction of Lumenis
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Ellex
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ellex
-
Figure Sales and Growth Rate Analysis of Ellex
-
Figure Revenue and Market Share Analysis of Ellex
-
Table Product and Service Introduction of Ellex
-
